DRESDEN-concept
Organisational unit: Interdisciplinaryinstitution
Contact
- TUD website: https://dresden-concept.de/
Related content and researchers (public profile)
- Research output
- Journals
- Activities
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling
Teleanu, M.-V., Fuss, C. T., Paramasivam, N., Pirmann, S., Mock, A., Terkamp, C. & Kircher, S. & 10 others, Landwehr, L.-S., Lenschow, C., Schlegel, N., Stenzinger, A., Jahn, A., Fassnacht, M., Glimm, H., Hübschmann, D., Fröhling, S. & Kroiss, M., Jul 2023, In: Molecular Oncology. 17, 7, p. 1343-1355 13 p.Research output: Contribution to journal › Research article › Contributed
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome
PTEN Study Group & Jahn, A., 10 Jan 2023, In: Journal of the National Cancer Institute. 115, 1, p. 93-103 11 p.Research output: Contribution to journal › Research article › Contributed
Influence of the First Wave of the COVID-19 Pandemic on Cancer Care in a German Comprehensive Cancer Center
Kirchberg, J., Rentsch, A., Klimova, A., Vovk, V., Hempel, S., Folprecht, G. & Krause, M. & 4 others, Plodeck, V., Welsch, T., Weitz, J. & Fritzmann, J., 23 Nov 2021, In: Frontiers in Public Health. 9, p. 750479 750479.Research output: Contribution to journal › Research article › Contributed › peer-review
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
FLOT4-AIO Investigators, 11 May 2019, In: The Lancet. 393, 10184, p. 1948-1957 10 p.Research output: Contribution to journal › Research article › Contributed › peer-review
The Extracellular, Cellular, and Nuclear Stiffness, a Trinity in the Cancer Resistome-A Review
Deville, S. S. & Cordes, N., 2019, In: Frontiers in oncology. 9, p. 1376Research output: Contribution to journal › Review article › Contributed › peer-review
Frontiers in Public Health
ISSNs: 2296-2565
Frontiers Media S.A., Switzerland
Scopus rating (2022): CiteScore 3.8 SJR 1.125 SNIP 1.374
Indexed in DOAJ
Journal
The Lancet
ISSNs: 0140-6736
Additional searchable ISSN (electronic): 1474-547X
Elsevier Science B.V.
Scopus rating (2024): CiteScore 87.6 SJR 12.113 SNIP 22.724
Journal
Frontiers in Oncology
ISSNs: 2234-943X
Frontiers Media SA
Scopus rating (2023): CiteScore 6.2 SJR 1.066 SNIP 0.831
Indexed in DOAJ
Journal
Journal of the National Cancer Institute: JNCI
ISSNs: 0027-8874, 0361-5960, 0069-0112
Additional searchable ISSN (electronic): 1460-2105
Oxford University Press
Scopus rating (2024): CiteScore 17.4 SJR 5.703 SNIP 2.657
Journal
Molecular Oncology
ISSNs: 1574-7891
Additional searchable ISSN (electronic): 1878-0261
Wiley & Sons, Chichester [u. a.]
Scopus rating (2024): CiteScore 11.4 SJR 1.957 SNIP 1.103
Indexed in DOAJ
Journal
LifeTechLab 02/2023
Zyla, A. A. (Participant), Schmidt, A. (Participant), Steinebrunner, I. (Chair)30 Oct 2023 → 1 Dec 2023
Activity: Organising or participating in an event › Participating in an event